Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification

Fig. 2

Proportion of immunogenic neoantigens from published literature predicated by TruNeo and other software. 19 out 1599 published mutations were identified with pre-existing T-cell responses. Non-expressed mutations were removed for each software except TruNeo. Neoantigens were ranked by each software with given order. TruNeo could identified more neoantigens than MHCflurry in Top 5, Top 10 and Top 20 level. The RANDOM recall was the expected recall to randomly pick 20, 10, or 5 candidates out of the 1599 mutations, thus 19/1599 = 1.19%

Back to article page